Regional
Central California Emergency Medical Services
Central California Emergency Medical Services (Fresno, CA) carries 28 drugs across 125 dose entries in its current published protocol, effective 2026-08-18.
Drugs and doses28
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | pages 51, 74 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | pages 51, 74 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | page 76 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 76 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | pages 77, 78 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 77, 78 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 31, 79 |
| Asthma / bronchospasm | peds | 5 mg | NEB | not captured | standing | pages 31, 79 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 24, 25, 80, 81 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 24, 25, 80, 81 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 25, 29, 80, 81 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 25, 29, 80, 81 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 162 mg | PO | not captured | standing | pages 29, 75 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 15, 82 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 15, 82 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | page 82 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 82 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1000 mg | IV/IO | not captured | standing | page 84 |
| Cardiac arrest | adult | 1000 mg | IV/IO | not captured | standing | pages 25, 84 |
| Hyperkalemia | adult | 1000 mg | IV/IO | not captured | standing | pages 25, 84 |
| Other | adult | 1000 mg | IV/IO | not captured | standing | page 84 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 25, 38, 40, 41, 48, 85 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 25, 38, 40, 41, 48, 85 |
| Other | adult | 25 g | IV/IO | not captured | standing | pages 25, 38, 40, 41, 48, 85 |
| Other | peds | 5 mL/kg | IV/IO | not captured | standing | pages 25, 38, 40, 41, 48, 85 |
| Seizure | adult | 25 g | IV/IO | not captured | standing | pages 40, 41, 85 |
| Seizure | peds | 5 mL/kg | IV/IO | not captured | standing | pages 40, 41, 85 |
| Status epilepticus | adult | 25 g | IV/IO | not captured | standing | pages 40, 41, 85 |
| Status epilepticus | peds | 5 mL/kg | IV/IO | not captured | standing | pages 40, 41, 85 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IM | not captured | standing | page 87 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 87 |
| Anaphylaxis | adult | 50 mg | IV/IM | not captured | standing | page 87 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 87 |
| Other | adult | 50 mg | IV/IM | not captured | standing | page 87 |
| Other | adult | 50 mg | IV/IM | not captured | standing | page 87 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 87 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 87 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5–30 mcg/kg | IV | not captured | standing | page 88 |
| Hypotension / shock | adult | 5–30 mcg/kg | IV | not captured | standing | page 88 |
| Sepsis | adult | 5–30 mcg/kg | IV | not captured | standing | page 88 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.4 mg | IM | not captured | standing | pages 89, 90 |
| Allergic reaction | peds | 0.01 mg/kg | IM | not captured | standing | pages 89, 90 |
| Asthma / bronchospasm | adult | 0.01 mg/kg | IM | not captured | standing | pages 31, 32, 89, 90 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 31, 32, 89, 90 |
| Bradycardia | peds | 0.01 mg | IV/IO | not captured | standing | pages 89, 90 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 24, 89, 90 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 24, 89, 90 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM/IN | not captured | standing | pages 29, 51, 91 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 29, 51, 91 |
| Post-intubation sedation | adult | 25–100 mcg | IV/IO/IM/IN | not captured | standing | page 91 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 91 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 92 |
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 92 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 92 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 92 |
| Other | adult | 20–40 mg | IV | not captured | standing | page 92 |
| Other | peds | 1 mg/kg | IV | not captured | standing | page 92 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 93 |
| Other | adult | 1 mg | IM | not captured | standing | page 38 |
| Other | peds | 1 mg | IN | not captured | standing | page 38 |
| Other | peds | 1 mg | IM | not captured | standing | page 38 |
| Status epilepticus | adult | 1 mg | IM | not captured | standing | page 41 |
| Status epilepticus | peds | 1 mg | IN | not captured | standing | page 41 |
| Status epilepticus | peds | 1 mg | IM | not captured | standing | page 41 |
Ipecac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 30 mL | PO | not captured | standing | page 94 |
| Other | adult | 30 mL | PO | not captured | standing | page 94 |
| Other | adult | 30 mL | PO | not captured | standing | page 94 |
| Other | peds | 15 mL | PO | not captured | standing | page 94 |
| Other | peds | 15 mL | PO | not captured | standing | page 94 |
| Other | peds | 15 mL | PO | not captured | standing | page 94 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.25 mg/kg | IV | not captured | standing | pages 51, 96 |
| Mild to moderate pain | adult | 0.25 mg/kg | IM/IN | not captured | standing | pages 51, 96 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IO | not captured | standing | page 97 |
| Other | adult | 100 mg | IV/IO | not captured | standing | page 97 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 97 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 97 |
| Wide-complex tachycardia | adult | 100 mg | IV/IO | not captured | standing | page 97 |
| Wide-complex tachycardia | adult | 100 mg | IV/IO | not captured | standing | page 97 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 97 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 97 |
| VF / pulseless VT | adult | 100 mg | IV/IO | not captured | standing | page 97 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 97 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 31 |
| COPD | adult | 2 g | IV | not captured | standing | page 31 |
| Eclampsia / pre-eclampsia | adult | 5 g | IV | not captured | standing | page 98 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | page 98 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mg | IV | not captured | standing | page 29 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 16 |
| RSI induction | adult | 0.1 mg/kg | IV | not captured | standing | page 99 |
| RSI induction | adult | 0.2 mg/kg | IM | not captured | standing | page 99 |
| RSI induction | peds | 0.1 mg/kg | IV | not captured | standing | page 99 |
| RSI induction | peds | 0.2 mg/kg | IM | not captured | standing | page 99 |
| Seizure | adult | 0.1 mg/kg | IN | not captured | standing | pages 40, 42 |
| Seizure | adult | 0.1 mg/kg | IM | not captured | standing | pages 40, 42 |
| Seizure | peds | 0.1 mg/kg | IN | not captured | standing | pages 40, 42 |
| Seizure | peds | 0.1 mg/kg | IM | not captured | standing | pages 40, 42 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–5 mg | IV | not captured | standing | page 100 |
| Burns | adult | 2–5 mg | IV | not captured | standing | page 100 |
| Burns | peds | 0.1 mg/kg | IV | not captured | standing | page 100 |
| CHF / pulmonary edema | adult | 2–5 mg | IV | not captured | standing | page 100 |
| Other | adult | 2–5 mg | IV | not captured | standing | page 100 |
| Trauma / hemorrhage | adult | 2–5 mg | IV | not captured | standing | page 100 |
| Trauma / hemorrhage | peds | 0.1 mg/kg | IV | not captured | standing | page 100 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1 mg | IM | not captured | standing | page 37 |
| Opioid overdose | adult | 1 mg | IV | not captured | standing | page 37 |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | page 37 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 37 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 29, 102 |
| ACS / chest pain | adult | 1 inch | TD | not captured | standing | pages 29, 103 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 33, 102 |
| CHF / pulmonary edema | adult | 1 inch | TD | not captured | standing | pages 33, 103 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | pages 51, 104 |
| Nausea / vomiting | adult | 4 mg | PO | not captured | standing | pages 51, 104 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IM | not captured | standing | pages 51, 104 |
| Nausea / vomiting | peds | 4 mg | PO | not captured | standing | pages 51, 104 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 107 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 107 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 25, 107 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 107 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 107 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 107 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.25 mg | SQ | not captured | standing | page 108 |
| Asthma / bronchospasm | adult | 1 puff | not captured | not captured | standing | page 108 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 46, 109 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 5 mg | IV | not captured | standing | page 110 |